Post by Egle Therapeutics

We’re excited to be attending the 26th edition of #Bio€quity Europe in Prague, Czech Republic, from May 4-6! Our CEO, John Celebi, will be presenting at 3:00 p.m. CEST on Tuesday, May 5, 2026, to share more about Egle Therapeutics and our work advancing Treg-modulating therapies. We look forward to connecting across the biotech community to discuss our approach and the progress we are making across our pipeline in autoimmune diseases and oncology. If you’ll be in Prague, we’d welcome the opportunity to get in touch!